COMPANY
Eliaz Therapeutics
Funding and NIH signals
- SEC Form D raise Raised $850K (Form D filed Oct 24, 2025). SEC Form D 0001062993-25-016285 (Oct 24, 2025)
Evidence (1 event)
- Oct 24, 2025 · SEC Form D 0001062993-25-016285
Name of Issuer: Eliaz Therapeutics Inc.; CIK: 2042609; Address: Santa Rosa, CA; Submission type: D; Filing date: 2025-10-24; Industry Group: Biotechnology; Date of First Sale: 2025-03-28; Types of Securities Offered: Other (SAFEs); Business combination transaction: false; Total Offering Amount: 850000; Total Amount Sold: 850000; Federal exemptions: 06b
- Oct 24, 2025 · SEC Form D 0001062993-25-016285